Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Kezar Life Sciences (KZR) Accumulated Depreciation & Amortization (2021 - 2025)

Kezar Life Sciences' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $721000.0 for Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization fell 7.68% year-over-year to $721000.0; the TTM value through Sep 2025 reached $721000.0, down 7.68%, while the annual FY2024 figure was $1.0 million, 2.44% down from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2025 was $721000.0 at Kezar Life Sciences, up from $494000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.1 million in Q3 2023 and bottomed at $251000.0 in Q1 2025.
  • The 5-year median for Accumulated Depreciation & Amortization is $902000.0 (2022), against an average of $1.6 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization rose 4.2% in 2023 before it plummeted 84.81% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.7 million in 2021, then crashed by 71.99% to $1.0 million in 2022, then increased by 4.2% to $1.1 million in 2023, then fell by 2.44% to $1.0 million in 2024, then crashed by 30.67% to $721000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Accumulated Depreciation & Amortization are $721000.0 (Q3 2025), $494000.0 (Q2 2025), and $251000.0 (Q1 2025).